Last reviewed · How we verify

NCT06825767

Comparison of the Effectiveness of High-Intensity and Low-Intensity Laser Therapies in Primary Knee Osteoarthritis

Completed NA Last updated 13 February 2025
What this trial tests

NA trial testing Conventional Treatment in Primary Knee Osteoarthritis in 72 participants. Completed in 1 October 2021.

Timeline
1 October 2020
Primary endpoint
1 June 2021
1 October 2021

Quick facts

Lead sponsorAnkara City Hospital Bilkent
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment72
Start date1 October 2020
Primary completion1 June 2021
Estimated completion1 October 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Ankara City Hospital Bilkent

Who can join

Adults 55 to 75, any sex, with Primary Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our primary goal is to investigate the advantages of low-intensity laser therapy (LLLT) and high-intensity laser therapy (HILT) over conventional therapy in patients with knee osteoarthritis (OA), our secondary goal is to investigate the advantages of HILT and LLLT; to compare its analgesic effects, its effects on functional status and quality of life, and its effects on femoral cartilage thickness.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Harnessing Photo-Energy Conversion in Nanomaterials for Precision Theranostics.
    Shi J, Fan Y, Zhang Q, Huang Y, et al · · 2025 · cited 4× · PMID 40376855 · DOI 10.1002/adma.202501623

Verify or expand the search:

Other trials of Conventional Treatment

Trials testing the same drug.

Other Ankara City Hospital Bilkent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06825767.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing